New insights for development of a safe and protective RSV vaccine.

Blanco, Jorge C G; Boukhvalova, Marina S; Shirey, Kari Ann; Prince, Gregory A; Vogel, Stefanie N

Blanco, Jorge C G; Boukhvalova, Marina S; Shirey, Kari Ann; Prince, Gregory A; Vogel, Stefanie N.

Affiliation

Blanco JC; Virion Systems Inc., Rockville, MD, USA. jblanco@virionsystmes.com

Hum Vaccin ; 6(6): 482-92, 2010 Jun.

Article in En | MEDLINE | ID: mdl-20671419

Subject(s)

Respiratory Syncytial Virus Infections/prevention & control; Respiratory Syncytial Virus Vaccines/immunology; Respiratory Syncytial Viruses/immunology; Adaptive Immunity; Animals; Clinical Trials as Topic; Host-Pathogen Interactions; Humans; Immunity, Innate; Respiratory Syncytial Virus Infections/pathology; Respiratory Syncytial Virus Infections/virology; Respiratory Syncytial Virus Vaccines/adverse effects; Respiratory Syncytial Viruses/pathogenicity; Toll-Like Receptor 4/immunology; Toll-Like Receptor 4/metabolism; Viral Fusion Proteins/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Viruses / Respiratory Syncytial Virus Infections / Respiratory Syncytial Virus Vaccines Limits: Animals / Humans Language: En Journal: Hum Vaccin Journal subject: ALERGIA E IMUNOLOGIA Year: 2010 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google